Retina Northwest, PC
Portland, Oregon 97221
2 studies enrolling now · 36 studies all time
What they study most
Age Related Macular Degeneration, Age Related Macular Degeneration (ARMD), Age-Related Macular Degeneration, Age-related Macular Degeneration, Cataract, Central Retinal Vein Occlusion, Choroidal Neovascularization, Diabetic Macular Edema, Diabetic Retinopathy, Full-thickness Macular Holes (MH), Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration
Studies at this site
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) — Recruiting now
- Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants — Recruiting now
- An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
- ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) — Running, not enrolling
- Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy — Completed
- A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — Completed
- A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration — Running, not enrolling
- ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD) — Completed
- NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) — Completed
- A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B — Completed
- A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A — Completed
- ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA — Completed
- DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME — Completed
- Anti-VEGF Treatment for Prevention of PDR/DME — Completed
- Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
- Effects of Pneumatic Vitreolysis on Vitreomacular Traction — Completed
- A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema — Completed
- Effects of Pneumatic Vitreolysis on Macular Hole — Completed
- Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) — Stopped early
- Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy — Completed
- Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) — Completed
- Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
- Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema — Completed
- Alpha Lipoic Acid in Geographic Atrophy — Completed
- Treatment for CI-DME in Eyes With Very Good VA Study — Completed
- Evaluation of Vitrectomy for Diabetic Macular Edema — Completed
- Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema — Completed
- Phase II Combination Steroid and Anti-VEGF for Persistent DME — Completed
- Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial — Completed
- A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) — Completed
- Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema — Completed
- Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy — Completed
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) — Completed
- Age-Related Eye Disease Study 2 (AREDS2) — Completed
- Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD) — Completed
- Complications of Age-Related Macular Degeneration Prevention Trial — Completed